Quick Contact

If you need any further info contact us:
enquiries@sourcebioscience.com
Tel:+44 (0) 115 973 9012
Fax:+44 (0) 115 973 9013

Email alerts

To automatically receive RNS news alerts, press releases and our latest news direct to your inbox, please subscribe to our email alerts service. It's free, and you can unsubscribe at any time.

Our latest news



Pennine Acute Hospitals NHS Trust adopts automated imaging

Source BioScience is pleased to announce that a second NHS Trust, Pennine Acute Hospitals NHS Trust, has committed to implementing its automated cervical cancer screening technology, BD FocalPoint™. The agreement is worth £0.4 million and the term of the agreement is up to March 2014.

For More Information

Source BioScience Director/PDMR Shareholding

The Company has been notified that Mr Laurie Turnbull, Chairman of Source BioScience, has purchased a total of 800,000 shares in the Company (500,000 on 12 January and 300,000 on 16 January), both purchases having been announced to the London Stock Exchange. Mr Turnbull how has a total holding of 4,450,000 shares, representing 2.18% of the issued share capital of the Company.

Source BioScience attendance at Arab Health 2012

Source BioScience is pleased to be attending the forthcoming Arab Health Conference in Dubai from 23 to 26 January.

The LifeSciences division is already a trusted and leading European provider of DNA sequencing, genomic services and bioinformatic analyses to healthcare and research markets. The Healthcare division provides screening and reference laboratory diagnostic testing for cancer and other diseases, and additional predictive testing for treatment optimisation for clinicians and patients. Through both divisions, the Company is expanding its service offering and expertise into the Middle East scientific and healthcare community.

Senior management from Source BioScience, including Dr Nick Ash, CEO and Dr Khosrow Shami, Sales Director will be on hand to offer advice and discuss solutions for your healthcare and life science research requirements, as well as to discuss areas of mutual interest and collaboration.

Find us at Stand RD34.

Full details of the Company’s services portfolio is available at www.sourcebioscience.com

Launch of Overnight Sequencing Service in Leeds

Source BioScience has extended the reach of its super fast DNA sequencing and data analysis service in the UK with the launch of its Overnight Service in Leeds. For more information about our sequencing service please visit www.lifesciences.sourcebioscience.com

2012  2011  2010  2009  2008  2007